BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1

Bristol Myers Squibb revealed in its first-quarter 2024 earnings report on Thursday that it will implement a sweeping “strategic productivity initiative” in a bid to generate approximately $1.5 billion in cost savings through 2025, including eliminating around 2,200 jobs by the end of 2024.